Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (401-410 of 1,726) with videos related to

Pageof 173
Sort By:
The New England Journal of Medicine|October 6, 1983
Sensitivity to collagen in thromboangiitis obliteransJ S Smolen, P Weidinger, E J Menzel
Molecular Immunology|August 1, 1981
Immunological cross-reactivity between the collagen-like fragment of human Clq and human type I collagenE J Menzel, J S Smolen, K B Reid
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1990
Lipocortins are major substrates for protein kinase C in extracts of human neutrophilsS J Stoehr, J E Smolen, S J Suchard
The American Journal of Pathology|August 1, 1986
Expression of a granule membrane marker on the surface of neutrophils permeabilized with digitonin. Correlations with Ca2+-induced degranulationJ E Smolen, R F Todd, L A Boxer
Journal of the American Medical Women'S Association (1972)|January 1, 1987
Interpersonal stress in medical education: correlates for men and women studentsD A Spiegel, R C Smolen, K A Hopfensperger
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1981
Characterization of autologous rosette-forming cells: a nonrestricted phenomenonJ S Smolen, S O Sharrow, A D Steinberg
Arthritis and Rheumatism|December 30, 2009
Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alonePatrick Garnero, Elizabeth Thompson, Thasia Woodworth, et al.
Arthritis Research & Therapy|July 6, 2017
Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibitionM Schoels, F Alasti, J S Smolen, et al.
Journal of Pharmaceutical Sciences|March 1, 1975
Drug-biomolecule interactions: bioelectrometric study of the mechanism of carbachol interactions with the cornea and its relation to miotic activityV F Smolen, C S Park, E J Williams
International Immunology|March 30, 2012
Targeting TNF receptors in rheumatoid arthritisStephan Blüml, Clemens Scheinecker, Josef S Smolen, et al.
Pageof 173

Showing results (401-410 of 1,726) with videos related to

Sort By:
Pageof 173
The New England Journal of Medicine|October 6, 1983
Sensitivity to collagen in thromboangiitis obliteransJ S Smolen, P Weidinger, E J Menzel
Molecular Immunology|August 1, 1981
Immunological cross-reactivity between the collagen-like fragment of human Clq and human type I collagenE J Menzel, J S Smolen, K B Reid
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1990
Lipocortins are major substrates for protein kinase C in extracts of human neutrophilsS J Stoehr, J E Smolen, S J Suchard
The American Journal of Pathology|August 1, 1986
Expression of a granule membrane marker on the surface of neutrophils permeabilized with digitonin. Correlations with Ca2+-induced degranulationJ E Smolen, R F Todd, L A Boxer
Journal of the American Medical Women'S Association (1972)|January 1, 1987
Interpersonal stress in medical education: correlates for men and women studentsD A Spiegel, R C Smolen, K A Hopfensperger
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1981
Characterization of autologous rosette-forming cells: a nonrestricted phenomenonJ S Smolen, S O Sharrow, A D Steinberg
Arthritis and Rheumatism|December 30, 2009
Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alonePatrick Garnero, Elizabeth Thompson, Thasia Woodworth, et al.
Arthritis Research & Therapy|July 6, 2017
Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibitionM Schoels, F Alasti, J S Smolen, et al.
Journal of Pharmaceutical Sciences|March 1, 1975
Drug-biomolecule interactions: bioelectrometric study of the mechanism of carbachol interactions with the cornea and its relation to miotic activityV F Smolen, C S Park, E J Williams
International Immunology|March 30, 2012
Targeting TNF receptors in rheumatoid arthritisStephan Blüml, Clemens Scheinecker, Josef S Smolen, et al.
Pageof 173